CHAMPIONS ONCOLOGY, INC. (CSBR)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 04-30. Amounts in USD.

Revenue Quarterly

0 1M 2M 3M Q1 '17: 925K Q2 '17: 717K Q3 '17: 726K Q4 '17: 892K Q1 '18: 683K Q2 '18: 551K Q3 '18: 627K Q4 '18: 708K Q1 '19: 518K Q2 '19: 740K Q3 '19: 879K Q4 '19: 918K Q1 '20: 870K Q2 '20: 977K Q3 '20: 1.3M Q4 '20: 1.1M Q1 '21: 1.2M Q2 '21: 1.3M Q3 '21: 1.5M Q4 '21: 1.5M Q1 '22: 1.6M Q2 '22: 1.6M Q3 '22: 1.5M Q4 '22: 1.6M Q1 '23: 1.7M Q2 '23: 1.7M Q3 '23: 1.8M Q4 '23: 1.8M Q1 '24: 1.7M Q2 '24: 1.8M Q3 '24: 1.8M Q4 '24: 1.8M Q1 '25: 1.7M Q2 '25: 1.8M Q3 '25: 1.8M Q4 '25: 2.3M Q1 '26: 1.9M Q2 '26: 2M Q3 '26: 2.7M Q4 '26: 2.8M Q1 '18 Q2 '19 Q3 '20 Q4 '21 Q1 '23 Q2 '24 Q3 '25 Q4 '26

Gross Profit Quarterly

-7.5M -5M -2.5M 0 2.5M 5M 7.5M Q1 '18: -2M Q2 '18: -2.1M Q3 '18: -1.8M Q1 '19: -2.6M Q2 '19: -2.7M Q3 '19: -2.5M Q1 '20: -2.9M Q2 '20: -2.9M Q3 '20: -3M Q4 '20: -4M Q1 '21: -4.1M Q2 '21: -4.3M Q3 '21: -3.1M Q4 '21: -4.4M Q1 '22: -3.8M Q2 '22: -4M Q3 '22: -4.9M Q4 '22: -4.6M Q1 '23: -5.4M Q2 '23: -5.7M Q3 '23: -5.9M Q4 '23: -5.5M Q1 '24: -6M Q2 '24: -4.8M Q3 '24: -6.1M Q4 '24: -5.5M Q1 '25: -5.4M Q2 '25: -5.7M Q3 '25: -4.8M Q4 '25: -5M Q1 '26: -6.1M Q2 '26: -5.3M Q3 '26: -6.2M Q4 '26: -4M Q1 '19 Q3 '20 Q4 '21 Q1 '23 Q2 '24 Q3 '25 Q4 '26

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income Quarterly

-4M -2M 0 2M 4M 6M Q3 '16: -2.4M Q4 '16: -2.5M Q1 '17: -2.5M Q2 '17: -493K Q3 '17: -1.4M Q4 '17: -2.4M Q1 '18: -619K Q2 '18: -70K Q3 '18: -67K Q4 '18: -599K Q1 '19: 481K Q2 '19: 275K Q3 '19: -370K Q4 '19: -116K Q1 '20: -614K Q2 '20: 291K Q3 '20: 433K Q4 '20: -2M Q1 '21: 24K Q2 '21: 7K Q3 '21: 982K Q1 '22: -175K Q2 '22: 263K Q3 '22: 830K Q4 '22: -311K Q1 '23: -284K Q2 '23: 7K Q3 '23: -2.5M Q4 '23: -2.5M Q1 '24: -2.6M Q2 '24: -2M Q3 '24: -2.6M Q4 '24: -271K Q1 '25: 1.3M Q2 '25: 732K Q3 '25: 4.5M Q1 '26: -527K Q2 '26: 185K Q3 '26: -276K Q4 '26: -522K Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q4 '22 Q1 '24 Q2 '25 Q4 '26

Net Income Quarterly

-4M -2M 0 2M 4M 6M Q3 '16: -2.4M Q4 '16: -2.6M Q1 '17: -2.5M Q2 '17: -504K Q3 '17: -1.4M Q4 '17: -2.4M Q1 '18: -674K Q2 '18: -94K Q3 '18: -76K Q4 '18: -632K Q1 '19: 483K Q2 '19: 267K Q3 '19: -369K Q4 '19: -253K Q1 '20: -641K Q2 '20: 307K Q3 '20: 75K Q4 '20: -2.2M Q1 '21: 75K Q2 '21: 1K Q3 '21: 959K Q1 '22: -172K Q2 '22: 277K Q3 '22: 787K Q4 '22: -344K Q1 '23: -319K Q2 '23: -16K Q3 '23: -2.4M Q4 '23: -2.6M Q1 '24: -2.6M Q2 '24: -2.1M Q3 '24: -2.5M Q4 '24: -109K Q1 '25: 1.3M Q2 '25: 728K Q3 '25: 4.5M Q1 '26: -436K Q2 '26: 268K Q3 '26: -279K Q4 '26: -667K Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q4 '22 Q1 '24 Q2 '25 Q4 '26

Cost of Revenue Quarterly

0 3.5M 7M 10.5M Q1 '18: 2.6M Q2 '18: 2.7M Q3 '18: 2.5M Q1 '19: 3.1M Q2 '19: 3.5M Q3 '19: 3.4M Q1 '20: 3.8M Q2 '20: 3.9M Q3 '20: 4.3M Q4 '20: 5M Q1 '21: 5.3M Q2 '21: 5.6M Q3 '21: 4.6M Q4 '21: 5.8M Q1 '22: 5.4M Q2 '22: 5.6M Q3 '22: 6.4M Q4 '22: 6.2M Q1 '23: 7.1M Q2 '23: 7.4M Q3 '23: 7.7M Q4 '23: 7.3M Q1 '24: 7.7M Q2 '24: 6.6M Q3 '24: 7.8M Q4 '24: 7.2M Q1 '25: 7.1M Q2 '25: 7.4M Q3 '25: 6.6M Q4 '25: 7.3M Q1 '26: 8M Q2 '26: 7.3M Q3 '26: 8.8M Q4 '26: 6.8M Q1 '19 Q3 '20 Q4 '21 Q1 '23 Q2 '24 Q3 '25 Q4 '26

Operating Cash Flow Quarterly

-5M -2.5M 0 2.5M 5M 7.5M Q1 '17: -2.4M Q2 '17: 116K Q3 '17: -684K Q4 '17: 167K Q1 '18: -1.9M Q2 '18: 268K Q3 '18: 445K Q4 '18: 9K Q1 '19: 336K Q2 '19: 64K Q3 '19: 1.2M Q4 '19: 252K Q1 '20: -279K Q2 '20: 360K Q3 '20: 279K Q4 '20: 2.5M Q1 '21: -715K Q2 '21: 879K Q3 '21: 135K Q4 '21: -2M Q1 '22: 216K Q2 '22: 1.2M Q3 '22: 4.3M Q4 '22: 796K Q1 '23: -195K Q2 '23: 3.3M Q3 '23: 1.6M Q4 '23: -692K Q1 '24: -4M Q2 '24: 589K Q3 '24: -919K Q4 '24: -1.8M Q1 '25: 311K Q2 '25: -283K Q3 '25: 490K Q4 '25: 6.9M Q1 '26: 600K Q2 '26: -1.7M Q3 '26: -1.3M Q4 '26: -2M Q1 '18 Q2 '19 Q3 '20 Q4 '21 Q1 '23 Q2 '24 Q3 '25 Q4 '26

Free Cash Flow Quarterly

-5M -2.5M 0 2.5M 5M 7.5M Q1 '17: -2.5M Q2 '17: 103K Q3 '17: -835K Q4 '17: -418K Q1 '18: -2.9M Q2 '18: 236K Q3 '18: 370K Q4 '18: -203K Q1 '19: 125K Q2 '19: -211K Q3 '19: 1M Q4 '19: 111K Q1 '20: -1M Q2 '20: 133K Q3 '20: 108K Q4 '20: 1M Q1 '21: -1.4M Q2 '21: 373K Q3 '21: -1.1M Q4 '21: -2.8M Q1 '22: -691K Q2 '22: 662K Q3 '22: 3.9M Q4 '22: 290K Q1 '23: -949K Q2 '23: 2.7M Q3 '23: 819K Q4 '23: -1.5M Q1 '24: -4.7M Q2 '24: 510K Q3 '24: -1M Q4 '24: -1.8M Q1 '25: 311K Q2 '25: -377K Q3 '25: 448K Q4 '25: 6.6M Q1 '26: 554K Q2 '26: -2M Q3 '26: -1.4M Q4 '26: -2.2M Q1 '18 Q2 '19 Q3 '20 Q4 '21 Q1 '23 Q2 '24 Q3 '25 Q4 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 25M 50M 75M Q2 '14: 66.9M Q3 '14: 66.9M Q1 '15: 5.8M Q2 '15: 5.7M Q3 '15: 5.6M Q1 '16: 8.7M Q2 '16: 8.7M Q3 '16: 8.7M Q1 '17: 9.8M Q2 '17: 11M Q3 '17: 11M Q1 '18: 11M Q2 '18: 11M Q3 '18: 11M Q1 '19: 12.6M Q2 '19: 14M Q3 '19: 11.5M Q1 '20: 11.6M Q2 '20: 13M Q3 '20: 13.7M Q1 '21: 14.2M Q2 '21: 15.1M Q3 '21: 14.5M Q1 '22: 13.4M Q2 '22: 14.5M Q3 '22: 14.4M Q1 '23: 13.5M Q2 '23: 13.5M Q3 '23: 13.6M Q1 '24: 13.5M Q2 '24: 13.5M Q3 '24: 13.6M Q1 '25: 14M Q2 '25: 14M Q3 '25: 14.4M Q1 '26: 13.8M Q2 '26: 14.5M Q3 '26: 13.9M Q1 '15 Q3 '16 Q2 '18 Q1 '20 Q3 '21 Q2 '23 Q1 '25 Q3 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-2.40 -1.60 -0.80 0.00 0.80 1.60 2.40 Q1 '14: -0.12 Q2 '14: -0.11 Q3 '14: -0.11 Q4 '14: -0.11 Q1 '15: -0.72 Q2 '15: -1.34 Q3 '15: -1.93 Q4 '15: -2.16 Q1 '16: -1.85 Q2 '16: -1.49 Q3 '16: -1.16 Q4 '16: -1.20 Q1 '17: -1.13 Q2 '17: -0.89 Q3 '17: -0.74 Q4 '17: -0.64 Q1 '18: -0.44 Q2 '18: -0.40 Q3 '18: -0.28 Q4 '18: -0.13 Q1 '19: -0.03 Q2 '19: -0.00 Q3 '19: -0.02 Q4 '19: 0.01 Q1 '20: -0.09 Q2 '20: -0.09 Q3 '21: -0.11 Q4 '22: 0.04 Q1 '23: 0.03 Q2 '23: 0.01 Q3 '23: -0.22 Q4 '23: -0.39 Q1 '24: -0.56 Q2 '24: -0.71 Q3 '24: -0.72 Q4 '24: -0.54 Q1 '25: -0.26 Q2 '25: -0.06 Q3 '25: 0.44 Q4 '26: -0.07 Q1 '15 Q2 '16 Q3 '17 Q4 '18 Q1 '20 Q2 '23 Q3 '24 Q4 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.